Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.
Schmidt G, Gerlinger C, Juhasz-Böss I, Stickeler E, Rody A, Liedtke C, Wimberger P, Link T, Müller E, Fehm T, Abel M, Stein S, Bohle R, Endrikat J, Solomayer EF.
Schmidt G, et al.
J Cancer Res Clin Oncol. 2016 Jun;142(6):1369-76. doi: 10.1007/s00432-016-2146-z. Epub 2016 Mar 23.
J Cancer Res Clin Oncol. 2016.
PMID: 27008006